|
FUNDC2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.31290000002527E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.51719999999622E-06 |
| Normal-vs-Stage2 |
1.088490E-02 |
| Normal-vs-Stage3 |
4.677700E-03 |
| Normal-vs-Stage4 |
1.743160E-01 |
| Stage1-vs-Stage2 |
9.825400E-01 |
| Stage1-vs-Stage3 |
6.777000E-01 |
| Stage1-vs-Stage4 |
8.055800E-02 |
| Stage2-vs-Stage3 |
7.706200E-01 |
| Stage2-vs-Stage4 |
2.389000E-01 |
| Stage3-vs-Stage4 |
3.021000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.0683999997545E-07 |
| Normal-vs-AfricanAmerican |
6.127400E-01 |
| Normal-vs-Asian |
2.840000E-01 |
| Caucasian-vs-AfricanAmerican |
3.119900E-02 |
| Caucasian-vs-Asian |
9.970100E-02 |
| AfricanAmerican-vs-Asian |
4.406200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.47050000000182E-05 |
| Normal-vs-Female |
9.7990999999964E-05 |
| Male-vs-Female |
5.917600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.918100E-02 |
| Normal-vs-Age(41-60Yrs) |
8.789800E-04 |
| Normal-vs-Age(61-80Yrs) |
4.30519999999879E-05 |
| Normal-vs-Age(81-100Yrs) |
1.096780E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.453600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.347400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.818200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.781600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.919200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.549200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.880370E-01 |
| Normal-vs-Grade 2 |
1.07440000007841E-07 |
| Normal-vs-Grade 3 |
4.410500E-04 |
| Normal-vs-Grade 4 |
6.690600E-01 |
| Grade 1-vs-Grade 2 |
5.924400E-01 |
| Grade 1-vs-Grade 3 |
9.422800E-01 |
| Grade 1-vs-Grade 4 |
1.477370E-01 |
| Grade 2-vs-Grade 3 |
2.413200E-01 |
| Grade 2-vs-Grade 4 |
3.73190000000356E-05 |
| Grade 3-vs-Grade 4 |
2.163900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.19179999202856E-09 |
| Normal-vs-ccB subtype |
5.709900E-02 |
| ccA subtype-vs-ccB subtype |
8.21410000000355E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.828000E-04 |
| Normal-vs-N1 |
8.790400E-01 |
| N0-vs-N1 |
1.698830E-01 |
|
|
